Chagas disease: Recombinant Trypanosoma cruzi antigens for serological diagnosis

Trends in Parasitology

Volumn 17, Issue 6, 2001, Pages 286-291

  Da Silveira, José Franco ^a   Umezawa, Eufrosina Setsu ^b   Luquetti, Alejandro Ostermayer ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN 1F8; ANTIGEN 30; ANTIGEN A 13; ANTIGEN AG 1; ANTIGEN AG 13; ANTIGEN AG2; ANTIGEN AG36; ANTIGEN B 12; ANTIGEN B 13; ANTIGEN CRA; ANTIGEN FCABP; ANTIGEN FRA; ANTIGEN H49; ANTIGEN J15; ANTIGEN J17; ANTIGEN J18; ANTIGEN J19; ANTIGEN MAP; ANTIGEN PEP 2; ANTIGEN SAPA; ANTIGEN TC 24; ANTIGEN TC 28; ANTIGEN TCD; ANTIGEN TCE; ANTIGEN TCN A; ANTIGEN TCR27; ANTIGEN TCR39; ANTIGEN TS; PARASITE ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

BLOOD DONOR; CHAGAS DISEASE; COMPLEMENT FIXATION; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMASTIGOTE; HEMAGGLUTINATION; HOST PARASITE INTERACTION; HUMAN; IMMUNOFLUORESCENCE TEST; NONHUMAN; REVIEW; SERODIAGNOSIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

EID: 0034979327     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(01)01897-9     Document Type: Review

References (42)

1. Chile and Brazil to be certified free of transmission of Chagas disease
2. Etiological treatment for Chagas disease
3. Risk of exposure to Chagas disease among seroreactive Brazilian blood donors
4. Collaboration on the standardisation of Chagas disease in the Americas: An appraisal
5. Comparison of genes encoding Trypanosoma cruzi antigens
6. The isolation of cloned genes
7. Characterisation of a high molecular weight immunodominant antigen associated to the cytoskeleton of Trypanosoma cruzi
8. Trypanosoma cruzi: Characterization of two recombinant antigens with potential application in the diagnosis of Chagas disease
9. Serodiagnosis of Chagas disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens
10. Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi
11. A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitation-confirmed and consensus-positive sera
12. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas disease
13. Cloning and partial characterization of a 28 kDa antigenic protein of Trypanosoma cruzi
14. Cloning and characterisation of a gene encoding a novel antigen of Trypanosoma cruzi
15. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins
16. Evaluation of recombinant trypomastigote surface antigens of Trypanosoma cruzi in screening sera from a population in rural Northeastern Brazil endemic for Chagas disease
17. Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family
18. Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein
19. Trypanosoma cruzi and human ubiquitin are immunologically distinct proteins despite only three amino acid difference in their primary sequence
20. Multicentre double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents
21. Recombinant antigens and Chagas disease diagnosis: Analysis of a workshop
22. Evaluation of recombinant antigens for Chagas disease serodiagnosis in South and Central America
23. Use of recombinant antigens for the diagnosis of Chagas disease and blood bank screening
24. Use of recombinant antigens for the accurate immunodiagnosis of Chagas disease
25. Chagas disease diagnosis: Evaluation of several tests in blood bank screening
26. Immunoassay with recombinant Trypanosoma cruzi antigens potentially useful for screening donated blood and diagnosing Chagas disease
27. A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas disease
28. Serological confirmation of Chagas disease by a recombinant peptide antigen line immunoassay: INNO-LIA chagas
29. Assay for detection of Trypanosoma cruzi antibodies in human sera based on reaction with synthetic peptides
30. Immunodetection of antibodies in sera from symptomatic and asymptomatic Chilean Chagas disease patients with Trypanosoma cruzi recombinant antigens
31. Evaluation of an enzyme-linked immunosorbent assay for the diagnosis of Chagas disease using synthetic peptides
32. Mapping of B cell epitopes in an immunodominant antigen of Trypanosoma cruzi using fusions to Escherichia coli lamB protein
33. Serodiagnosis of Chagas disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens
34. Serodiagnosis of Trypanosoma cruzi infection using the new particle gel immunoassay ID-PaGIA Chagas
35. Evaluation of a synthetic tripeptide as antigen for detection of IgM and IgG antibodies to Trypanosoma cruzi in serum samples from patients with Chagas disease or viral diseases
36. Multiepitope synthetic peptide and recombinant protein for detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas disease
37. Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection
38. Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns
39. Diagnostic value of detecting specific IgA and IgM with recombinant Trypanosoma cruzi antigens in congenital Chagas disease
40. Serum antibodies to Trypanosoma cruzi antigens in Atacamenos patients from highland of northern Chile
41. Immune response to Trypanosoma cruzi shed acute phase antigen in children from an endemic area for Chagas disease in Bolivia